RU2006117320A - Кристаллические формы гидрохлорида 3-бета-амино-17-метиленандростан-6-альфа-7-бета-диола - Google Patents

Кристаллические формы гидрохлорида 3-бета-амино-17-метиленандростан-6-альфа-7-бета-диола Download PDF

Info

Publication number
RU2006117320A
RU2006117320A RU2006117320/04A RU2006117320A RU2006117320A RU 2006117320 A RU2006117320 A RU 2006117320A RU 2006117320/04 A RU2006117320/04 A RU 2006117320/04A RU 2006117320 A RU2006117320 A RU 2006117320A RU 2006117320 A RU2006117320 A RU 2006117320A
Authority
RU
Russia
Prior art keywords
beta
alpha
amino
methyleneandrostan
diol
Prior art date
Application number
RU2006117320/04A
Other languages
English (en)
Russian (ru)
Inventor
Колетт КОЛЛАДАН (FR)
Колетт Колладан
Дени ПРА (FR)
Дени ПРА
Паскаль БИЙО (FR)
Паскаль Бийо
Александр ЖИЮЛИАНИ (FR)
Александр ЖИЮЛИАНИ
Ажи ЭЛЬМАЛЕ (FR)
Ажи Эльмале
Марк-Антуан ПЕРРЭН (FR)
Марк-Антуан ПЕРРЭН
Original Assignee
Инфлазим Фармасьютикалз, Лтд. (Ca)
Инфлазим Фармасьютикалз, Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0312257A external-priority patent/FR2861077B1/fr
Application filed by Инфлазим Фармасьютикалз, Лтд. (Ca), Инфлазим Фармасьютикалз, Лтд. filed Critical Инфлазим Фармасьютикалз, Лтд. (Ca)
Publication of RU2006117320A publication Critical patent/RU2006117320A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0011—Unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2006117320/04A 2003-10-20 2004-10-20 Кристаллические формы гидрохлорида 3-бета-амино-17-метиленандростан-6-альфа-7-бета-диола RU2006117320A (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US51267903P 2003-10-20 2003-10-20
FR0312257 2003-10-20
FR0312257A FR2861077B1 (fr) 2003-10-20 2003-10-20 Formes cristallines du chlorydrate de 3-beta-amino, 17-methylene, androstane-6-alpha, 7-beta-diol
US60/512,679 2003-10-20

Publications (1)

Publication Number Publication Date
RU2006117320A true RU2006117320A (ru) 2007-11-27

Family

ID=34466415

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006117320/04A RU2006117320A (ru) 2003-10-20 2004-10-20 Кристаллические формы гидрохлорида 3-бета-амино-17-метиленандростан-6-альфа-7-бета-диола

Country Status (8)

Country Link
EP (1) EP1680441A1 (fr)
JP (1) JP2007509050A (fr)
KR (1) KR20070007766A (fr)
AU (1) AU2004281998A1 (fr)
CA (1) CA2542821A1 (fr)
MX (1) MXPA06005679A (fr)
RU (1) RU2006117320A (fr)
WO (1) WO2005037851A1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE353909T1 (de) * 2000-04-28 2007-03-15 Inflazyme Pharm Ltd 3-stickstoff-6,7-dioxygenierte steroid verbindungen und verwendungen davon

Also Published As

Publication number Publication date
EP1680441A1 (fr) 2006-07-19
CA2542821A1 (fr) 2005-04-28
JP2007509050A (ja) 2007-04-12
MXPA06005679A (es) 2006-08-17
KR20070007766A (ko) 2007-01-16
WO2005037851A1 (fr) 2005-04-28
AU2004281998A1 (en) 2005-04-28

Similar Documents

Publication Publication Date Title
ES2882010T3 (es) Sales o cocristales de 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol
DE69927803T2 (de) Imidazo-pyridin verbindungen, die die sekretion von magensäure hemmen.
Wang et al. Drug–drug co-crystallization presents a new opportunity for the development of stable vitamins
ES2901955T3 (es) Sal meglumínica y formas cristalinas de la misma de un farmaco (delafloxacina)
ES2952770T3 (es) Formas de estado sólido de apalutamida
ES2652670T3 (es) Compuestos antifúngicos cristalinos
EP1622612B9 (fr) Formulation pharmaceutique du sel de sodium telmisartan
JP4530664B2 (ja) ２−メチル−４−（４−メチル−１−ピペラジニル）−１０Ｈ−チエノ［２，３−ｂ］［１，５］ベンゾジアゼピンの結晶形Ｉ、この結晶形Ｉの製造方法、及び医薬組成物
JP2011516511A5 (fr)
EP3164393B1 (fr) Dérivés de flavaglines
WO2019141957A1 (fr) Dérivés d'hydroxy pyrazole n-pyrimidinyle et utilisations associées
US11339181B2 (en) Crystalline forms of a Janus kinase inhibitor
ES2909799T3 (es) Derivados aminoacídicos de triptólido esterificados en el hidroxilo C14 y método de preparación y uso de los mismos
JP2012512145A (ja) フリバンセリンの結晶性の塩形態
CN101774958B (zh) N-正丙基-3-(4-甲基苯基)-4-(4-甲磺酰基苯基)-2,5-二氢吡咯-2-酮的i型结晶及其制造方法
ES2864277T3 (es) Sal de compuestos de ácido dicarboxílico
RU2006117320A (ru) Кристаллические формы гидрохлорида 3-бета-амино-17-метиленандростан-6-альфа-7-бета-диола
RU2004114278A (ru) Амид 8-амино-[1.2.4]триазоло-[1.5-а]пиридин-6-карбоновой кислоты
RU2008100036A (ru) Кристаллические формы производного пирролотриазина
CN111670189A (zh) 对rsv具有活性的环烷基取代的吡唑并嘧啶
KR20190136055A (ko) (s)-아폭솔라너의 결정질 형태
RU2006105481A (ru) Стабильные модификации гидромалеата тегасерода
JP5795693B2 (ja) 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
KR102275045B1 (ko) 모사프리드시트르산염수화물의 제조방법 및 이를 포함하는 약학제제
KR20170066196A (ko) 항아칸트아메바제 및 그 제조방법

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20090209